España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Ready Capital Corporation 5.75% Senior Notes due 2026
RCC
NYSE
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$24.10
0.08
0.33%
At Close: -
$24.03
-0.07
-0.29%
Pre-Market: Jun 28, 4:10 PM EDT
15 minutes delayed
Get Report
Comment
Ready Capital Corporation 5.75% Senior Notes due 2026 (RCC) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Ready Capital Corporation 5.75% Senior Notes due 2026 (NYSE:RCC) Stock
Ready Capital Corporation 5.75% Senior Notes due 2026 Stock (NYSE: RCC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, January 17, 2012
Jefferies' Aveo Pharmaceuticals Management Remains Confident in Differentiation From Inlyta
Benzinga
Monday, November 28, 2011
Canaccord Maintains Buy Rating and $28 PT on AVEO Pharmaceuticals
Benzinga
Tuesday, May 24, 2011
J.P. Morgan Ups PT On AVEO To $25
Benzinga
Wednesday, February 16, 2011
Astellas and AVEO Pharmaceuticals Enter into Agreement to Develop and Commercialize Tivozanib Outside of Asia
Benzinga
Friday, December 03, 2010
EU Label Expansion for Sutent - Analyst Blog
Benzinga
EU Label Expansion for Sutent - Analyst Blog
Benzinga
Monday, June 14, 2010
Progressive's Rating Revisions - Analyst Blog
Benzinga
Thursday, June 03, 2010
Novartis Presents Positive Data - Analyst Blog
Benzinga
Monday, April 26, 2010
Another Setback for Sutent - Analyst Blog
Benzinga
Friday, March 12, 2010
Twin Setbacks for Pfizer - Analyst Blog
Benzinga
Thursday, August 13, 2009
Paladin Labs Inc. Announces Sale of T-ACT Platform to IMBiotechnologies
Benzinga